Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 trial update evaluating chemotherapy plus bone marrow transplantation with filgrastim in patients with acute myeloid leukemia or mye…
-
CLINICAL_TRIALS trial_result · 2012-05-31Clinical Trial Update: Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]
A Phase 1/Phase 2 study of TLK199 tablets in patients with Myelodysplastic Syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Busulfan and Fludarabine in Patients With AML and MDS [Phase 2]
Phase 2 trial evaluating a busulfan and fludarabine regimen in patients with acute myeloid leukemia and myelodysplastic syndrome has complet…
-
CLINICAL_TRIALS withdrawal · 2012-05-10Clinical Trial Update: Palifermin After Haploidentical PBSCT [Phase 2]
A Phase 2 trial evaluating palifermin after haploidentical peripheral blood stem cell transplantation has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5 [Phase 2]
Phase 2 clinical trial update assessing lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with deletion 5q or mo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: AG-013736 (Axitinib) In Patients With Poor Prognosis Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS) [Phase 2]
Pfizer's axitinib (AG-013736) was studied in a Phase 2 trial in patients with poor-prognosis acute myeloid leukemia or myelodysplastic syndr…
-
CLINICAL_TRIALS research · 2012-03-16Clinical Trial Update: The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q). [Phase 2]
A Phase 2 trial is evaluating the efficacy of azacitidine with or without lenalidomide in high-risk myelodysplastic syndrome and acute myelo…
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating sirolimus plus tacrolimus for graft-versus-host disease prophylaxis after related stem cell transplantat…
-
CLINICAL_TRIALS trial_result · 2012-01-23Clinical Trial Update: Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation [Phase 2]
Phase 2 safety study evaluating the combination of azacitidine with donor lymphocyte infusion for relapsed acute myeloid leukemia or myelody…
-
CLINICAL_TRIALS research · 2012-01-13Clinical Trial Update: HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating HLA-haploidentical hematopoietic stem cell transplantation in children and adolescents with acute …
-
CLINICAL_TRIALS trial_result · 2011-11-18Clinical Trial Update: Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003
A multi-center trial update collecting survival data in subjects previously enrolled in Celgene protocol CC-5013-MDS-003 for myelodysplastic…
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS [Phase 2]
This is a Phase 2 clinical trial evaluating ClAraC or FLAMSA conditioning regimens followed by stem cell transplantation for high-risk acute…
-
CLINICAL_TRIALS trial_result · 2011-07-11Clinical Trial Update: Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®) [Phase 3]
A Phase 3 trial evaluating 5-azacitidine (Vidaza) for treatment of imminent hematologic relapse in patients with acute myeloid leukemia or m…
-
CLINICAL_TRIALS trial_result · 2011-07-11Clinical Trial Update: Phase II 5-Azacytidine Plus VPA Plus ATRA [Phase 2]
Phase II clinical trial evaluating a combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in myelodysplastic syndrome an…
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 1]
Phase 1 pharmacokinetic study evaluating a 3-hour infusion of decitabine in adults with acute myeloid leukemia or myelodysplastic syndrome.
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS) [Phase 2]
This Phase 2 trial evaluated three dosing schedules of low-dose decitabine in patients with myelodysplastic syndrome and chronic myelomonocy…
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: Treatment of Myelodysplastic Syndromes Comparing Hydralazine/Ac. Valproic and Supportive Care in Patients Not Candidates, Refractory and/or Intolerant to Intensive Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating the combination of hydralazine and valproic acid compared with supportive care in myelodysplastic syndrome…
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS). [Phase 2]
This Phase 2 trial compares clofarabine alone versus clofarabine with low-dose cytarabine in previously untreated acute myeloid leukemia and…
-
CLINICAL_TRIALS research · 2011-04-21Clinical Trial Update: Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT) [Phase 4]
A Phase 4 clinical trial update examining busulfan and cyclophosphamide as a conditioning regimen for hematological malignancies, replacing …
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS [Phase 2]
Phase 2 trial evaluating cytokine-immunotherapy for low-risk myelodysplastic syndrome has completed. Results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]
A completed Phase I/II trial evaluating the combination of 5-azacytidine with cytarabine in patients with relapsed/refractory acute myeloid …
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen [Phase 3]
This update reports the completion of a Phase 3 trial comparing Busulfan plus Cyclophosphamide versus Fludarabine as conditioning regimens f…
-
CLINICAL_TRIALS research · 2010-12-03Clinical Trial Update: Reduced-intensity Conditioning Allogeneic Hematopoietic Cell Transplantation
This clinical trial update concerns reduced-intensity conditioning allogeneic hematopoietic cell transplantation for myelodysplastic syndrom…
-
CLINICAL_TRIALS research · 2010-11-23Clinical Trial Update: The Role of Erythropoietin in Myelodysplastic Syndrome
An update on a clinical trial examining erythropoietin as a treatment for myelodysplastic syndrome.
-
CLINICAL_TRIALS trial_result · 2010-10-22Clinical Trial Update: Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM) [Phase 1, Phase 2]
This trial update reports on the safety and anti-disease activity of CHR-2797 (tosedostat) in elderly and/or treatment-refractory patients w…